Crescentic glomerulonephritis without immune deposits: Clinicopathologic features. Of 46 patients with acute crescentic glomeruIonephritis involving 20 to 90% of glomeruli, 16 had no definable systemic disease and no significant glomerular immune deposits by immunofluorescent or electron microscopy. Anti-GBM antibody and circulating immune complexes were further excluded by radioimmunoassay and Raji cell assay in all patients tested. Clinical features included a 10:6 male female ratio, mean age of 58 years (range, 13-77), disease duration of less than 3 months, rapidly deteriorating renal function, and frequent pulmonary manifestations. Nine patients had oliguria, serum creatinine concentrations over 6 mgIlOO ml, and required dialysis, but three of these patients subsequently recovered renal function. These three patients and seven patients with creatinine concentrations of less than 6 mgIlOO ml have not progressed to chronic renal failure. In this series, idiopathic acute crescentic glomerulonephritis without immune deposits was more common than was immune complex or anti-GBM nephritis. The clinical, laboratory, and pathologic characteristics of these patients were similar to those reported in anti-GBM and immune-complex-induced gbmerulonephritis. These observations expand the spectrum of rapidly progressive crescentic glomerubonephritis. They suggest that glomerular immune deposits may be less important than other factors in determining the extent of renal injury and subsequent clinical course in crescentic gbomerulonephritis.
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Glomérulonéphrite avec croissants sans dëpdts immuns: Caractères anatomocliniques. Seize parmi 46 malades atteints de gbmerulonephrite aiguè avec croissants intéressant 20 a 90% des glomérules n'avaient pas de maladie de système reconnaissable et pas de ddpôts immuns significatifs en immunofluorescence ou en microscopie electronique. La presence d'anticorps anti-GBM et de complexes immuns circulants a été, de surcroit, éliminée chez tous les malades étudiés. Les caracténstiques cliniques comprennent un rapport 10:6 hommes:femmes, an age moyen de 58 ans (de 13 a 77), une durée de Ia maladie inférieure a 3 mois, une détérioration rapide de la fonction rénale et Ia fré-quence de manifestations pulmonaires. Neuf malades étaient It has long been recognized that rapid deterioration of renal function may complicate the course of glomerulonephritis associated with several systemic diseases, including poststreptococcal and other postinfectious glomerulonephritides, lupus erythematosus, Henoch-Schonlein purpura, Wegener's granulomatosis, polyarteritis nodosa, and other vasculidites [1, 2] . The pathologic hallmark of glomerulonephritis with rapid loss of renal function is the presence of extensive glomerular crescent formation [3, 4] . In 1968 Bancani et al reported eight patients with rapidly progressive glomerulonephritis and extensive crescent formation without evidence of preceding streptococcal infection or other systemic diseases [5] . The term idiopathic rapidly progressive glomerulonephritis (RPGN) subsequently has been applied to such cases by both clinicians and pathologists [6, 7] . More recent studies using immunofluorescent and electron microscopic techniques have attempted to define the pathogenesis of idiopathic RPGN. Lewis et al reported that six of seven patients with RPGN had antiglomerular basement membrane (GBM) antibody demonstrable in serum or kidney eluates, whereas only one patient had granular deposits consistent with immune complex disease [8] . Beirne et al have reported recently that 29 of their 40 patients with crescentic glomerulonephritis had anti-GBM disease [9] . In several other studies, most patients with crescentic glomerulonephritis have had findings more consistent with an immune complex pathogenesis 110 -13] .
Several recent studies focusing primarily on the morphologic aspects of crescentic glomerulonephritis mention patients with immunopathologic findings that are not characteristic of either immune complex or anti-GBM-induced glomerular disease [9] [10] [11] [12] [13] . Although these patients are generally considered rare or atypical, the prevalence of such cases in one series is stated to be equal to that of immune complex or anti-GBM antibody-induced RPGN, or about one third of all patients [20] . Numerous clinicopathologic studies of RPGN have been reported [5, 8-10, 12, 14, 19, 20] . Previous studies, however, have not differentiated patients on the basis of underlying immunopathogenetic mechanisms or focused clearly on those patients with RPGN without immune deposits. Since the course, prognosis, and response to therapy of various glomerular diseases seems clearly related to underlying disease mechanisms, more data on these patients with acute crescentic glomerulonephritis without immune deposits is required to document the full spectrum of RPGN. The present report analyzes the clinical, laboratory, and renal pathologic features of 16 such patients studied in detail over a 4-year period. In this combined series from two university medical centers, patients with acute crescentic glomerulonephritis without immune deposits or other clinical or serologic evidence of systemic disease represented 35% of the total number of patients with RPGN and crescents and were more common than patients with anti-GBM antibody or immune complex deposits in the total series.
Methods

Patient selection
A retrospective study was conducted of all patients undergoing renal biopsy at two university medical centers (Boston University and the University of Virginia) from 1974 through 1977. All patients reviewed were hospitalized at these institutions and evaluated and followed clinically by members of the Nephrology Services. All had adequate renal biopsy specimens examined by light, immunofluorescent (IF), and electron microscopy (EM). Forty-six patients with cellular crescent formation in glomeruli were identified. Crescents are defined as aggregates of cells proliferating in Bowman's space associated with fibrin demonstrable by light or IF microscopy. Glomeruli were said to contain crescents only if 25% or more of Bowman's space was occupied by extracapillary cellular proliferation. Fourteen patients with crescentic glomerulonephritis had significant granular glomerular immune deposits by IF or EM (see below), and specific diagnoses of systemic diseases could be made based on clinical, pathologic, or laboratory studies. One patient had malignant hypertension. Ten additional patients had linear IF staining for IgG on the GBM and circulating anti-GBM antibody and were classified as having anti-GBM nephritis. Five patients had granular immune deposits by IF or dense deposits or both, by EM, without systematic disease. Although we do not believe the glomerular deposits in these five patients were significant, they were arbitrarily classified as "idiopathic immune complex nephritis" to keep the "no deposit" group as homogenous as possible.
The remaining 16 patients with idiopathic crescentic glomerulonephritis without significant immune deposits as defined below form the basis of this report. In addition to crescentic glomerulonephritis without immune deposits, these patients also had the following characteristics: (1) negative tests for circulating immune complexes and anti-GBM antibody performed as outlined below, (2) evidence of acute and active disease documented by active urine sediments, increased protein excretion, and normal kidney size as measured by i.v. pyelogram, renal arteriogram, or examination at autopsy, (3) progressive loss of renal function as manifested by at least a twofold increase in serum creatinine concentration over baseline levels in a period of 1 to 3 months, and(4) disease of less than 3 month's duration as measured from the onset of symptoms or urinary abnormalities to the time of biopsy.
Renal pathology Light microscopy. Methods of tissue processing and staining have been described in detail elsewhere [8, 22] . All glomeruli in each biopsy specimen were evaluated for the presence of cellular crescents in Bowman's space, intracapillary proliferation, and necrosis. The latter two findings were difficult to quantitate in severely diseased kidneys. Therefore, the results are reported as positive if un- Electron microscopy. Techniques for ultrastructural study of biopsies at our institutions have been previously described [23, 27] . Sections of one or more glomeruli in each biopsy specimen were carefully studied for the presence of electron-dense deposits in the subepithelial or subendothelial spaces, within the basement membrane, or in the mesangium.
Laboratory studies
Antistreptolysin 0 titers (ASOT), lupus erythematosus (LE) cell preparations, antinuclear antibodies, cryoglobulins, hepatitis B surface antigen (HBsAg) levels, Coombs tests, and rheumatoid factor were measured by standard laboratory methods. C3 levels were measured by radial immunodiffusion with commercially supplied plates and standards (Hyland Division, Travenol Laboratories, Costa Mesa, CA). C'H50 levels were measured by a standard hemolytic assay [28] . Circulating antibody to DNA was measured by counter immunoelectrophoresis [29] in 11 patients. Further evidence for circulating immune complexes was sought in 11 patients by the Clq precipitin test [30] and the rheumatoid factor precipitin test [31] . These 11 sera samples were also tested for circulating immune complexes by the Raji cell radioimmune assay [32] . Antibody to GBM was tested for in all 16 patients by indirect IF on fresh normal human kidney, with known positive and negative controls as previous described [33] . The absence of antibody to GBM was further confirmed by radioimmunoassay in 11 representative sera samples [34] . Forty-six patients biopsied during the period of the study had acute crescentic glomerulonephritis. The diagnoses in these patients are listed in Table 1 .
Twenty-nine patients had definite glomerular immune deposits by IF or EM, and one had malignant hypertension. Ten patients had diffuse linear staining for IgG on the GBM consistent with anti-GBM nephritis. Anti-GBM antibody was detected in the circulation of all ten patients; by indirect IF in eight and by radioimmunoassay only in two. Two of the ten patients with anti-GBM antibody disease had pulmonary symptoms consistent with Goodpasture's syndrome. The remaining eight had idiopathic anti-GBM disease without pulmonary involvement. Four patients had immunoglobulin deposits localized primarily in the mesangium and composed predominantly of IgA. Three of these patients had other clinical manifestations of HenochSchonlein purpura, and one had only recurrent macroscopic hematuria consistent with IgG-IgA nephropathy. Three patients had diffuse proliferative lupus nephritis with crescents, three had membranoproliferativ e glomerulonephritis, and one each was seen with poststreptococcal nephritis, Wegener's granulomatosis, and polyarteritis nodosa. One patient had an unclassifiable disease characterized by electron dense deposits along the GBM, tubular basement membrane, and Bowman's capsule. Five patients had granular immune deposits without systemic disease and were classified as idiopathic immune complex nephritis. Two of these patients showed focal I + to 2 + granular deposits of 1gM or IgG in the mesangium and diffuse I + to 2+ granular deposits of C3 on the GBM with no deposits seen by EM. Three patients had small intramembranous, subendothelial, or mesangial electron dense deposits by EM with negative IF.
The remaining 16 patients, or 35% of the total patients studied, had no significant glomerular deposits by IF or EM and met the other criteria stated for inclusion in this study.
Clinical characteristics of patients with crescen tic glomerulonephritis without immune deposits Age and sex. The clinical features of the 16 patients in this category are summarized in Table 2 . Males outnumbered females 10 to 6, and the mean age of all patients was 58 years. Of the 16 patients, 13 were between 40 and 70-years-old, and the ages of the others were 13, 72 and 77 years.
Duration of disease and presenting signs and symptoms. In all 16 patients, the duration of disease was less than 3 months to the time of biopsy, as judged by onset of symptoms or documented abnormal laboratory findings (Table 2) . Kidney size was determined radiologically in 14 patients and at autopsy in 1 and was normal in 13 and slightly increased in 2 ( Table 2) . Of the 16 patients, 9 had documented normal urinalysis findings, serum creatinine concentrations, or both, within a year of onset of disease. Renal function prior to the onset of disease was not known in the remaining 7 patients.
Seven patients were uremic when first seen, and all seven presented with nonspecific symptoms of 1 to 4 week's duration which were consistent with renal failure, including weakness, nausea, anorexia, and weight loss. All of these patients, and two others with serum creatinine concentrations that reached 9.2 and 8.1 mg/l00 ml, manifested oliguria (less than 400 ml/day) at or shortly after admission.
Seven patients presented with decreasing renal function but with serum creatinine concentrations of less than 6 mg/lOO ml. None of these seven patients were oliguric when first seen. Five nonoliguric patients gave a history of a recent flulike illness, with weakness, fever, and polyarthralgias.
None had eosinophilia or abdominal complaints. Of the nine nonuremic patients, three presented with cough and hemoptysis. One patient had the onset of disease during treatment for an empyema and had underlying carcinoma of the lung. Five patients were initially seen for other complaints, including anemia, fatigue, hematuria, and shortness of breath. Of the 16 patients, 13 were normotensive on initial evaluation ( Table 2) . Two of the three patients with elevated blood pressures (> 150/90 mm Hg) had oliguria, creatinine concentrations of over 10 mg/100 ml, and clinical evidence of hypervolemia.
Associated clinical findings. The 16 patients had a variety of past medical problems or associated diseases which could not be clearly related to their glomerulonephritis (Table 2) . Two patients had histories of cardiovascular surgery within the year prior to the onset of renal disease, including a myocardial infarction with pericarditis and subsequent coronary bypass surgery and aortic valve surgery. Normal, <200 Todd units Normal C3, 100 to 200 mg/l00 ml; normal C'H50, 34 to 48 U Three patients had documented duodenal ulcer disease with bleeding. One patient each had a history of recent HB sAg positive hepatitis, sideroblastic anemia, Coombs-negative hemolytic anemia, untreated positive Hinton test, carcinoma of the lung, and alcoholism. Six patients had pulmonary manifestations, either transient pulmonary infiltrates or hemoptysis, or both, early in their course. No patient had a history of prior renal disease, or recent exposure to hydrocarbons, or other known nephrotoxins. In contrast to our previously reported findings in anti-GBM disease [35] , there was no apparent increase in reactivity to tuberculin skin tests in these patients. Seven of 16 patients were tested before treatment, and only two were positive.
Laboratory findings
The results of laboratory studies in all patients are presented in Table 3 . Except for laboratory abnormalities related to impaired renal function, the. only findings frequently present were anemia and elevations in the corrected erythrocyte sedimentation rate. Fourteen of 16 patients were anemic when first seen, and all 13 patients tested had elevated sedimentation rates (Table 3) . In four patients, the anemia appeared to be related to iron deficiency, and in one a Coomb's negative hemolytic anemia was present. The remaining patients had normochromic normocytic red cell indices without any apparent cause for anemia other than their renal disease. None of these patients had evidence of microangiopathic hemolytic anemia. Antinuclear antibodies (16 patients) and lupus erythematosus cell preparations (11 patients) were negative. Anti-DNA antibody levels were normal in the 11 patients tested. Serum complement levels, determined as levels of C3 (11 patients), total hemolytic complement (12 patients), or both (7 patients), were normal in all 16 patients (Table 3) . Antistreptolysin 0 titers were less than 200 Todd units in all 16 patients (Table 3) . Additional serologic studies (Table 3) included negative rheumatoid factor (10 patients), negative HBsAg levels (12 patients), (one patient had persistent positive tests of HBsAg) and nega- tive cryoglobulins (13 patients). Clq precipitin, rheumatoid factor precipitin, and Raji cell assays were negative in all 11 patients tested (Table 3) . Circulating anti-GBM antibody determined by indirect IF was absent in all 16 patients tested. The absence of elevated levels of antibody to GBM was confirmed by radioimmunoassay on sera from 11 representative patients (Table 3) .
Renal pathology Light microscopy. The results of light, IF, and EM studies of renal biopsies in all 16 patients are summarized in Table 4 . The biopsy specimens contained an average of 19 glomeruli, with a range of 4 to 41 glomeruli per biopsy. All but 2 biopsy specimens had more than 8 glomeruli available for study. Evidence of glomerular necrosis and fibrin deposition, or both, was present in 15 of 16 biopsy specimens, and all patients had crescent formation in 20% to 90% of glomeruli (Fig. 1, Table 4 ). In 11 of 16 biopsy specimens, crescent formation involved more than 50% of glomeruli. There was definite evidence of increased glomerular cellularity in 9 of 16 biopsy specimens (Table 4) . In some cases, collapse and compression were too extensive to allow assessment of proliferation. No evidence of vasculitis was found in the biopsy specimens of 14 patients. Two biopsy specimens had segmental necrotizing vasculitis in a single intralobular artery.
Interstitial inflammatory infiltrates varied from small aggregates of mononuclear cells to severe, diffuse infiltration by lymphocytes, plasma cells, and polymorphonuclear leukocytes. Most biopsy specimens were also characterized by moderate arterio and arteriolosclerosis.
Immunofluorescent microscopy. None of the 16 patients had glomerular IF deposits that exceeded those frequently seen in over 100 normal donor kidneys examined by us or those reported by others in patients without clinical or histologic evidence of renal disease [24] [25] [26] . In six patients, IF studies were entirely negative, except for positive staining for fibrin in crescents, a finding common to all 16 patients (Table 4) . C3 was present alone, in a focal and segmental distribution, in five patients and was associated with trace or 1+ amounts of 1gM in five patients (Table 4 , Fig. 1 ). The staining was generally confined to the mesangium of a few glomeruli with most glomeruli showing no staining. No patient had glomerular staining for IgG (Fig. 1) . No staining for immunoglobulins or complement was present in arteries in any biopsies. Some arterioles in three biopsy specimens showed 1+ to 2+ deposits of C3, a common finding in a variety of renal diseases.
Electron microscopy. EM studies confirmed IF results and demonstrated no significant electron dense deposits in the capillary wall or mesangium in any patient studied. The ultrastructural lesions in glomeruli were otherwise quite similar to the lesions in extracapillary glomerulonephritis described in detail by others [1, 2, 10, 16, 36] . They included wrinkling of the GBM, collapse of capillary tufts, necrosis, and occasional deposits of fibrin-like material. Ultrastructural gaps in the basement membrane were seen on routine EM studies in several patients [10, 16, 36] .
Treatment, course, and outcome. Treatment and followup data are presented in Fig. 2 . Adequate followup data were available in 15 of 16 patients. Nine patients required hemodialysis within 1 month of the time of biopsy (Fig. 2) . Six patients have remained on dialysis. Two of these received steroids without apparent benefit, and four were not treated.
All nine patients who reached dialysis presented with oliguria. Three patients required dialysis for 1 to 3 months, but renal function then improved, and subsequently serum creatinines have remained stable for periods of 5 to 24 months. All three patients who came off dialysis were treated with steroid "pulse" therapy [37] . One patient who presented with oliguria and a creatinine of 8.1 mgldl was treated with methylprednisolone "pulse" therapy and oral steroids. This patient died 4 months later of complications of gastrointestinal bleeding but had resolution of crescents and necrotizing glomerular lesions histologically at the time of death. No evidence of active or healed vasculitis was found in the kidneys or in any other organs at the time of autopsy examination in this patient. Eight of the ten patients who were not on dialysis at the time of this report have stable renal function, and only two are slowly deteriorating. All but two of these patients received therapy at some point with steroids, cyclophosphamide, or anticoagulants. None of the 16 patients in this series has developed nephrotic syndrome, hypertension, or other extrarenal manifestations of systemic disease during the period of follow up Discussion This report confirms the observations of others that acute crescentic glomerulonephritis occurs in man in the absence of detectable serologic, immunopathologic, or ultrastructural evidence of gbmerular deposition of anti-GBM antibody or immune complexes [9] [10] [11] [12] [13] [15] [16] [17] [18] [19] [20] [21] . Moreover, in our combined series, patients with crescentic glomerulonephritis without glomerular immune deposits outnumbered patients who had identifiable anti-GBM antibody or immune complex-induced renal disease. Patients without any identifiable glomerular immunopathology represented the largest group in the series and accounted for 35% of all patients studied. This figure probably does not differ significantly from those reported by others [21, 381 . The present study, however, represents the first systematic review of the clinical, laboratory, and pathologic characteristics of such patients.
Although the clinical features and prognosis of most diseases depend on the pathogenetic mechanisms underlying them, the patients described here ])1,2)t [8, 9] or immune complex-induced [9] [10] [11] [12] [13] [14] [15] glomerular lesions. Thus, the 10 to 6 male predominance, mean age of 58 years, age range of 13 to 77 years, insidious onset with nonspecific presenting signs and symptoms, and unfavorable outcome in patients with oliguria are clinical features common to several other studies when cases of poststreptococcal disease are excluded [2, 5, 7, 9, 14, 39] . Other clinical findings in our patients, which have been emphasized also by others, include the frequency of preceding upper respiratory tract infections (5 patients) [14, 401 , malignancy (1 patient) [14, 41, 42] , increased erythrocyte sedimentation rate (11 patients) [39] , generally normal blood pressures [20, 39] , and an overall survival of 30% to 50% without dialysis or transplantation [10, 14, 19] .
The pulmonary involvement in 6 of 16 patients in our study does not appear significantly different in type and frequency from that reported by Beirne et al [9] , although in their series all patients with pulmonary disease had anti-GBM nephritis. The anemia seen in all but one of our patients has not been emphasized by others in patients without chronic renal failure or pulmonary hemorrhage. Anemia was clearly present early, and out of proportion to the degree of renal failure, in several of our patients. As in previous reports the number of patients involved and the variety of treatments used preclude any valid conclusions regarding the efficacy of any of the therapeutic regimens.
The histologic findings in these patients also differed little from those reported in detail in other patients with crescentic glomerulonephritis due to anti-GBM antibody or immune complex deposition [5, 6, 8-11, 14, 19, 201 . Some authors have required 50% [10, 14] or even 70% [43, 44] crescents to classify patients as idiopathic RPGN, and several studies have emphasized the relation between the extent of crescent formation and ultimate outcome [9, 10, 13, 14, 45] . Of our 16 pateints, 11 had 50% or more crescents, but those with less than 50% crescents appeared to have a similar disease. Indeed, in contrast to other studies [9, 10, 13, 14, 45] , the percentage of glomeruli with crescent formation correlated poorly with severity of disease at the time of biopsy as judged by serum creatinine concentrations.
Correlation was also poor with eventual outcome, as previously noted [46] . Only five of nine patients presenting with oliguric renal failure and creatinine concentrations greater than 6 mg/dl had over 50% crescents. Of the seven patients followed for 4 to 26 months with stable or improved renal function and creatinine concentrations of less than 6 mg/dl, five had over 50% crescents. In contrast to the findings of others [10, 20] , we did not find the presence of endocapillary proliferation to be a useful prognostic index. Most patients with severe clinical disease also had extensive interstitial infiltrates.
Despite the similarity of the clinical and histologic characteristics in our patients and those reported previously in RPGN mediated by immune complex or anti-GBM deposition, the serologic, IF, and EM studies performed showed no evidence of either mechanism in any of the patients studied. Several possible explanations for these findings should be considered. The absence or linear immunoglobulin deposits on the GBM by direct IF as well as the absence of detectable antibody to GBM in the serum by indirect IF in all 16 patients, findings confirmed by the more sensitive radioimmunoassay method in 11 patients, make it unlikely that anti-GBM antibody disease was overlooked. Once present, anti-GBM antibody deposits in glomeruli have been shown to remain detectable by IF in both man and experimental animals for many months [47, 48] .
Thus, it is quite unlikely that such deposits disappeared between the onset of disease and the time of biopsy I to 3 months later. With regard to a possible immune complex pathogenesis, we believe that this mechanism also was effectively excluded. Although EM has been shown to be somewhat less sensitive than IF is in detecting early glomerular complex deposits [49] , electron dense deposits are characteristically seen in active immune complexinduced glomerular lesions [50] . Careful studies of multiple thin sections in each renal biopsy failed to reveal any such deposits. IF studies were entirely negative in six patients. Five patients had only trace to 1+ focal and segmental deposits of C3. Six patients had similar amounts of 1gM and C3 in a few glomeruli, although most glomeruli in all patients were free of deposits. Such deposits are frequently seen in kidneys without clinical or histologic evidence of glomerular disease [24-261. Moreover, severe glomerulonephritis has not been reported in man or animals due to glomerular deposition of immune complexes containing 1gM as the only immunoglobulin. No deposits of IgG were detected in any of the patients reported here. Additional evidence against an immune complex pathogenesis is provided by the normal complement levels in all patients and the absence of detectable complexes in the circulation by the rheumatoid factor, Clq precipitin, and Raji cell assays. Although available methods for the detection of circulating complexes remain less reliable than those for measuring anti-GBM antibodies jj34], the methods used here, particularly the Raji cell assay, have all been shown to give positive results in diseases mediated by circulating immune complex deposition [32, 34, 51, 52] . The possibility that glomerular complex deposits were not detected because of the interval between the onset of disease and the time of biopsy also seems unlikely. In an acute, self limited, presumably immune complex-induced nephritis, such as that following streptococcal infection, electron dense deposits have often been shown to resolve within 3 months, but abnormal IF findings generally persist for a much longer time [53, 541.
Finally, although the glomerular lesions in the patients reported here did not appear to be consequent to glomerular immunoglobulin deposits, undetected immunologic mechanisms still might be involved in their pathogenesis. Evidence of vasculitis was present in single vessels in two of our patients, although similar lesions have been reported in other patients with glomerulonephritis due to mechanisms that do not involve systemic vasculitis [8, 55] . It is also widely recognized that crescentic glomerulonephritis accompanying some forms of vasculitis may have no deposits demonstrable by IF or EM [1, 7, 12, 36, 38] . Although some of the associated findings such as weakness, anemia, and increased sedimentation rate are consistent with vasculitis, the diagnosis of primary glomerular disease rather than vasculitis in our patients is supported by the lack of necrotizing vascular lesions on biopsy in 14 patients and the paucity of extrarenal signs of vasculitis despite extensive diagnostic studies and prolonged observation. We cannot exclude, however, the possibility that some form of systemic vascular disease resulted in the glomerular lesions in these patients. Although most forms of vasculitis are believed to result from vascular deposition of circulating immune complexes, as demonstrated in the experimental serum sickness models [56, 57] , Germuth et al have shown that a severe proliferative glomerulonephritis may develop also in the absence of gbmerular immune deposits when repeated injections of antigen are administered to maintain antigen excess [58] . O'Regan, Smith, and Drummond also have reported the production of significant proteinuria in animals infused with preformed immune complexes without detectable glomerular complex deposition [59] . These studies suggest that soluble immune complexes that do not deposit in glomeruli can be primary mediators of glomerular damage [58] .
The patients reported here contribute to fully documenting the clinicopathologic spectrum of nonstreptococcal RPGN. In our experience, the absence of gbomerular immune deposits in acute crescentic glomerulonephritis is a more common finding than is the presence of deposits consistent with either immune complex or anti-GBM antibody-induced disease. The absence of deposits does not appear to correlate with any specific clinical or light microscopic pattern. This observation and the heterogeneity of IF findings (and presumably pathogenetic mechanisms) in RPGN suggest that the degree of glomerular injury and subsequent clinical course in these patients may be determined less by the type and quantity of immune deposits than by other factors which are common to all pathogenetic mechanisms involved.
